Yamauchi, P.; Chen, C.-C.; Ding, Y.; al., et. Secukinumab Is Associated With Improvements in Real-World Effectiveness Outcomes Through 12 Months of Follow-Up in Patients With Plaque Psoriasis: Analysis of US Dermatology Electronic Medical Records. J of Skin 2019, 3, 173.